Novo Nordisk — Drug Prices & Medicare Spending

Novo Nordisk manufactures 12 drugs tracked by Medicare Part D with total spending of $15.3B.

Drugs Tracked

$15.3B

Medicare Spending

$387.22

Avg Cost/Claim

92%

Have Generics

Novo Nordisk Drugs — Ranked by Medicare Spending

#	Drug	Generic Name	Cost/Claim	Medicare Spending	YoY Change	Generic?
1	Ozempic	Semaglutide	$685.00	$5.0B	+72.5%	No
2	Wegovy	Semaglutide (weight)	$820.00	$2.3B	+185.6%	Yes
3	Rybelsus	Semaglutide (oral)	$428.00	$1.8B	+38.7%	Yes
4	Tresiba	Insulin Degludec	$262.00	$1.5B	+8.9%	Yes
5	NovoLog	Insulin Aspart	$139.00	$1.2B	-19.3%	Yes
6	Levemir	Insulin Detemir	$167.00	$812.0M	-24.6%	Yes
7	Victoza	Liraglutide	$424.00	$789.0M	-31.2%	Yes
8	Norditropin	Somatropin	$2,286.00	$567.0M	-4.2%	Yes
9	Fiasp	Insulin Aspart (fast-acting)	$245.00	$456.0M	+12.3%	Yes
10	Saxenda	Liraglutide (weight)	$399.00	$345.0M	-28.4%	Yes
11	Xultophy	Insulin Degludec/Liraglutide	$399.00	$345.0M	+8.4%	Yes
12	Sogroya	Somapacitan	$2,070.00	$178.0M	+42.4%	Yes

Novo Nordisk manufactures 12 drugs tracked by Medicare Part D, with total annual spending of $15.3B.

Norditropin (Somatropin) is the most expensive at $2,286.00 per claim.

11 of 12 Novo Nordisk drugs (92%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.